Tag Archives: MD

Drug Shows Potential for Treating Duchenne’s Muscular Dystrophy

An experimental drug called eteplirsen has shown potential as a treatment for Duchenne’s Muscular Dystrophy (DMD), Sarepta Therapeutics, Inc. announced today. The drug, which so far has shown no serious side effects, enabled boys to walk longer than those who … Continue reading

Posted in News | Tagged , , , , | Leave a comment